Johnson & Johnson requests emergency authorization from FDA

Johnson & Johnson requests emergency authorization from FDA

February 5, 2021: Johnson & Johnson applied for an emergency use authorization from the Food and Drug Administration for its vaccine against the coronavirus disease after releasing data last week, which shows it was about 66% effective in giving protection.

Envisioning A Seamless World | Brooke LeVasseur

Envisioning A Seamless World | Brooke LeVasseur

ConcertoHealth, a globally capitated medical group managing 24,000 dual-eligible and Medicare patients, faced challenges in providing its patients with appropriate access to timely and effective specialist consultations.